Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antibody drug conjugate (ADC) are essentially anti-cancer drugs. ADC has broad application in prostate cancer, skin cancer, leukemia, pancreatic cancer, lymphoma, renal cancer, ovarian cancer, colon cancer, multiple myeloma, lung cancer, breast cancer, glioblastoma and other cancer types.
The Americas will lead the market over the forecast period. The contribution of nanotechnology to the development of antibody drug conjugates (ADC), manufacturing processes and technological advances have contributed to the growth of the global antibody drug conjugate market in this region. The global demand for Antibody Drug Conjugates Market is expected to generate revenue of around USD 2863.51 Million by end of 2026, growing at a CAGR of around 7.3 % between 2020 and 2026.
Advances in medical technology, increased cancer rates, and increased obesity are all factors that are driving the market for antibody drug conjugates. In addition, the growing cooperation between biopharmaceuticals and research institutions will also play a role in promoting the development of antibody drug conjugates market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antibody Drug Conjugates market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antibody Drug Conjugates market. Detailed analysis of key players, along with key growth strategies adopted by Antibody Drug Conjugates industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
F Hoffman-La Roche
Genentech
Immunogen
Takeda Pharmaceutical
Seattle Genetics
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals
Novartis AG
Pfizer
By Type:
Kadcyla
Adcertis
By End-User:
Blood Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Brain Tumor
others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antibody Drug Conjugates Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antibody Drug Conjugates Market Size and Growth Rate of Kadcyla from 2016 to 2027
-
1.3.2 USA Antibody Drug Conjugates Market Size and Growth Rate of Adcertis from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antibody Drug Conjugates Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
1.4.2 USA Antibody Drug Conjugates Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.3 USA Antibody Drug Conjugates Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027
-
1.4.4 USA Antibody Drug Conjugates Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
1.4.5 USA Antibody Drug Conjugates Market Size and Growth Rate of Brain Tumor from 2016 to 2027
-
1.4.6 USA Antibody Drug Conjugates Market Size and Growth Rate of others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antibody Drug Conjugates Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antibody Drug Conjugates by Major Types
-
3.4.1 Market Size and Growth Rate of Kadcyla
-
3.4.2 Market Size and Growth Rate of Adcertis
4 Segmentation of Antibody Drug Conjugates Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antibody Drug Conjugates by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antibody Drug Conjugates in Blood Cancer
-
4.4.2 Market Size and Growth Rate of Antibody Drug Conjugates in Breast Cancer
-
4.4.3 Market Size and Growth Rate of Antibody Drug Conjugates in Ovarian Cancer
-
4.4.4 Market Size and Growth Rate of Antibody Drug Conjugates in Lung Cancer
-
4.4.5 Market Size and Growth Rate of Antibody Drug Conjugates in Brain Tumor
-
4.4.6 Market Size and Growth Rate of Antibody Drug Conjugates in others
5 Market Analysis by Regions
-
5.1 USA Antibody Drug Conjugates Production Analysis by Regions
-
5.2 USA Antibody Drug Conjugates Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antibody Drug Conjugates Landscape Analysis
-
6.1 West USA Antibody Drug Conjugates Landscape Analysis by Major Types
-
6.2 West USA Antibody Drug Conjugates Landscape Analysis by Major End-Users
7 South USA Antibody Drug Conjugates Landscape Analysis
-
7.1 South USA Antibody Drug Conjugates Landscape Analysis by Major Types
-
7.2 South USA Antibody Drug Conjugates Landscape Analysis by Major End-Users
8 Middle West USA Antibody Drug Conjugates Landscape Analysis
-
8.1 Middle West USA Antibody Drug Conjugates Landscape Analysis by Major Types
-
8.2 Middle West USA Antibody Drug Conjugates Landscape Analysis by Major End-Users
9 Northeast USA Antibody Drug Conjugates Landscape Analysis
-
9.1 Northeast USA Antibody Drug Conjugates Landscape Analysis by Major Types
-
9.2 Northeast USA Antibody Drug Conjugates Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 F Hoffman-La Roche
-
10.1.1 F Hoffman-La Roche Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Genentech
-
10.2.1 Genentech Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Immunogen
-
10.3.1 Immunogen Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Takeda Pharmaceutical
-
10.4.1 Takeda Pharmaceutical Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Seattle Genetics
-
10.5.1 Seattle Genetics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Progenics Pharmaceuticals
-
10.6.1 Progenics Pharmaceuticals Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Bayer Healthcare Pharmaceuticals
-
10.7.1 Bayer Healthcare Pharmaceuticals Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Novartis AG
-
10.8.1 Novartis AG Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Pfizer
-
10.9.1 Pfizer Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Kadcyla from 2016 to 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Adcertis from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of Brain Tumor from 2016 to 2027
-
Figure USA Antibody Drug Conjugates Market Size and Growth Rate of others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antibody Drug Conjugates Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antibody Drug Conjugates Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antibody Drug Conjugates
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antibody Drug Conjugates by Different Types from 2016 to 2027
-
Table Consumption Share of Antibody Drug Conjugates by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Kadcyla
-
Figure Market Size and Growth Rate of Adcertis
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antibody Drug Conjugates by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antibody Drug Conjugates by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Blood Cancer
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Ovarian Cancer
-
Figure Market Size and Growth Rate of Lung Cancer
-
Figure Market Size and Growth Rate of Brain Tumor
-
Figure Market Size and Growth Rate of others
-
Table USA Antibody Drug Conjugates Production by Regions
-
Table USA Antibody Drug Conjugates Production Share by Regions
-
Figure USA Antibody Drug Conjugates Production Share by Regions in 2016
-
Figure USA Antibody Drug Conjugates Production Share by Regions in 2021
-
Figure USA Antibody Drug Conjugates Production Share by Regions in 2027
-
Table USA Antibody Drug Conjugates Consumption by Regions
-
Table USA Antibody Drug Conjugates Consumption Share by Regions
-
Figure USA Antibody Drug Conjugates Consumption Share by Regions in 2016
-
Figure USA Antibody Drug Conjugates Consumption Share by Regions in 2021
-
Figure USA Antibody Drug Conjugates Consumption Share by Regions in 2027
-
Table West USA Antibody Drug Conjugates Consumption by Types from 2016 to 2027
-
Table West USA Antibody Drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure West USA Antibody Drug Conjugates Consumption Share by Types in 2016
-
Figure West USA Antibody Drug Conjugates Consumption Share by Types in 2021
-
Figure West USA Antibody Drug Conjugates Consumption Share by Types in 2027
-
Table West USA Antibody Drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table West USA Antibody Drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antibody Drug Conjugates Consumption Share by End-Users in 2016
-
Figure West USA Antibody Drug Conjugates Consumption Share by End-Users in 2021
-
Figure West USA Antibody Drug Conjugates Consumption Share by End-Users in 2027
-
Table South USA Antibody Drug Conjugates Consumption by Types from 2016 to 2027
-
Table South USA Antibody Drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure South USA Antibody Drug Conjugates Consumption Share by Types in 2016
-
Figure South USA Antibody Drug Conjugates Consumption Share by Types in 2021
-
Figure South USA Antibody Drug Conjugates Consumption Share by Types in 2027
-
Table South USA Antibody Drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table South USA Antibody Drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antibody Drug Conjugates Consumption Share by End-Users in 2016
-
Figure South USA Antibody Drug Conjugates Consumption Share by End-Users in 2021
-
Figure South USA Antibody Drug Conjugates Consumption Share by End-Users in 2027
-
Table Middle West USA Antibody Drug Conjugates Consumption by Types from 2016 to 2027
-
Table Middle West USA Antibody Drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antibody Drug Conjugates Consumption Share by Types in 2016
-
Figure Middle West USA Antibody Drug Conjugates Consumption Share by Types in 2021
-
Figure Middle West USA Antibody Drug Conjugates Consumption Share by Types in 2027
-
Table Middle West USA Antibody Drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antibody Drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antibody Drug Conjugates Consumption Share by End-Users in 2016
-
Figure Middle West USA Antibody Drug Conjugates Consumption Share by End-Users in 2021
-
Figure Middle West USA Antibody Drug Conjugates Consumption Share by End-Users in 2027
-
Table Northeast USA Antibody Drug Conjugates Consumption by Types from 2016 to 2027
-
Table Northeast USA Antibody Drug Conjugates Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antibody Drug Conjugates Consumption Share by Types in 2016
-
Figure Northeast USA Antibody Drug Conjugates Consumption Share by Types in 2021
-
Figure Northeast USA Antibody Drug Conjugates Consumption Share by Types in 2027
-
Table Northeast USA Antibody Drug Conjugates Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antibody Drug Conjugates Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antibody Drug Conjugates Consumption Share by End-Users in 2016
-
Figure Northeast USA Antibody Drug Conjugates Consumption Share by End-Users in 2021
-
Figure Northeast USA Antibody Drug Conjugates Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of F Hoffman-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffman-La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffman-La Roche
-
Figure Revenue and Market Share Analysis of F Hoffman-La Roche
-
Table Product and Service Introduction of F Hoffman-La Roche
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Immunogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunogen
-
Figure Sales and Growth Rate Analysis of Immunogen
-
Figure Revenue and Market Share Analysis of Immunogen
-
Table Product and Service Introduction of Immunogen
-
Table Company Profile and Development Status of Takeda Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
-
Table Product and Service Introduction of Takeda Pharmaceutical
-
Table Company Profile and Development Status of Seattle Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics
-
Figure Sales and Growth Rate Analysis of Seattle Genetics
-
Figure Revenue and Market Share Analysis of Seattle Genetics
-
Table Product and Service Introduction of Seattle Genetics
-
Table Company Profile and Development Status of Progenics Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals
-
Table Product and Service Introduction of Progenics Pharmaceuticals
-
Table Company Profile and Development Status of Bayer Healthcare Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Bayer Healthcare Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Bayer Healthcare Pharmaceuticals
-
Table Product and Service Introduction of Bayer Healthcare Pharmaceuticals
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
